Editas Medicine
$22.479876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$22.47
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
-$1.22 (-5.15%) As of 3:53 PM EST today
-$1.22 (-5.15%) Today
Why Robinhood?
You can buy or sell EDIT and other stocks, options, ETFs, and crypto commission-free!
About EDIT
Editas Medicine, Inc. engages in the development and commercialization of genome editing technology. Its technology includes clustered, regularly interspaced short palindromic repeats (CRISPR); and CRISPR associated protein 9 (Cas9). Read More The company was founded by Feng Zhang, Jennifer A. Doudna, George McDonald Church, J. Keith Joung and David R. Liu on September 3, 2013 and is headquartered in Cambridge, MA.
Employees
133
Headquarters
Cambridge, Massachusetts
Founded
2013
Market Cap
1.35B
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
802.33K
High Today
$24.29
Low Today
$22.43
Open Price
$24.00
Volume
815.36K
52 Week High
$34.37
52 Week Low
$19.29
Collections
Analyst Ratings
56%
of 9 ratings
Buy
56%
Hold
44%
Sell
0%
EDIT Earnings
-$0.82
-$0.55
-$0.27
$0.00
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Q3 2019
Q4 2019
Estimated
— per share
Actual
Available Feb 26, After Hours
People Also Bought
CRISPR
26,944
$49.85
-4.06%Intellia Therapeutics
5,373
$12.03
-4.37%Sangamo Therapeutics
4,943
$6.83
-3.39%Illumina
4,584
$269.54
-4.12%Teladoc Health
10,907
$119.69
+4.75%Micron Technology
44,476
$51.82
-5.80%bluebird bio
2,101
$72.88
-4.42%Bristol-Myers Squibb Comp...
$3.52
-3.55%Bristol-Myers Squibb
7,779
$61.77
-3.44%JD.com
28,658
$38.75
-1.57%iQIYI
31,834
$23.98
-0.85%NVIDIA
93,039